NASDAQ:DALS DA32 Life Science Tech Acquisition (DALS) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free DALS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.30▼$10.3250-Day Range$10.25▼$10.3252-Week Range$9.68▼$11.22Volume2,200 shsAverage Volume88,802 shsMarket Capitalization$264.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get DA32 Life Science Tech Acquisition alerts: Email Address Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here About DA32 Life Science Tech Acquisition Stock (NASDAQ:DALS)DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.Read More Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here DALS Stock News HeadlinesApril 26, 2024 | msn.comLife science SMEs “heading out of the funding winter”April 23, 2024 | finance.yahoo.comBellevue Life Sciences Acquisition Corp. (BLACU)April 26, 2024 | WealthPress (Ad)The system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.February 7, 2024 | news.yahoo.comDefense Innovation Unit’s tech-scaling strategy focuses on partnershipsDecember 29, 2023 | seekingalpha.comBLACR Bellevue Life Sciences Acquisition Corp.August 2, 2023 | finance.yahoo.comDeerfield Management Company, L.P. (Series C) Boosts Holding in DA32 Life Science Tech ...July 26, 2023 | usnews.comMissouri University of Science and TechnologyJuly 21, 2023 | finance.yahoo.comDA32 Life Science Tech Acquisition Corp. Announces Redemption of SharesApril 26, 2024 | WealthPress (Ad)The system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.June 24, 2023 | uk.news.yahoo.comScore a gorgeous TV for a just $80 (that's 50% off) — plus 4 more epic tech deals todayJune 21, 2023 | investing.comLife Science Technology Inc (285770)May 2, 2023 | bizjournals.comDanaher completes merger of Cytiva and Pall Corp.'s life sciences businessApril 1, 2023 | cbsnews.comBest spring deals at Walmart this week: Save on home, tech, Easter and moreMarch 23, 2023 | usnews.comInfinity Math Science and Tech High SchoolFebruary 20, 2023 | benzinga.comACROMETA Acquires Controlling Stake in Co-Working Lab Space Company Life Science Incubator (LSI)February 17, 2023 | morningstar.comDA32 Life Science Tech Acquisition Corp Class A DALS Stock QuoteFebruary 16, 2023 | usnews.comHammond Academy of Science and TechFebruary 6, 2023 | news.yahoo.comDanaher Takes Interest in Life Sciences Firm CatalentFebruary 4, 2023 | reuters.comDanaher interested in buying life sciences firm Catalent- Bloomberg NewsFebruary 2, 2023 | msn.comMark Zuckerberg just ushered in a new era of tech, where profitability and efficiency trump perks and cultureJanuary 5, 2023 | newsweek.comTECH & SCIENCEJanuary 5, 2023 | businessinsider.comThe Trade Desk just made a move to wrest control of ads powered by first-party data away from GoogleDecember 17, 2022 | wsj.comDA32 Life Science Tech Acquisition Corp. Cl ASeptember 9, 2022 | tmcnet.comLife Science Analytics Global Market to Reach $37.86 Billion by 2026September 7, 2022 | apnews.comDatadobi’s Latest StorageMAP Update Enables IT Leaders to Significantly Reduce Liability and RiskAugust 25, 2022 | investing.comDa32 Life Science Tech Acquisition Corp (DALS)August 16, 2022 | fool.comDA32 Life Science Tech Acquisition Corp.(DALS)See More Headlines Receive DALS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DA32 Life Science Tech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:DALS CUSIPN/A CIK1863294 Webda32lifescience.tech Phone212551600FaxN/AEmployees2,021Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$600,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-37.55% Return on Assets0.85% Debt Debt-to-Equity RatioN/A Current Ratio0.36 Quick Ratio0.36 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.02 per share Price / Cash Flow441.92 Book Value($0.18) per share Price / Book-57.33Miscellaneous Outstanding SharesN/AFree FloatN/AMarket Cap$264.71 million OptionableNot Optionable BetaN/A 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Steven Kafka Ph.D. (Age 54)CEO & Director Mr. Christopher E. Wolfe (Age 43)CFO & Sec. Comp: $90kKey CompetitorsWorld Quantum Growth AcquisitionNYSE:WQGAExecutive Network PartneringNYSE:ENPCArtemis Strategic InvestmentNASDAQ:ARTEPatria Latin American Opportunity AcquisitionNASDAQ:PLAOPearl Holdings AcquisitionNASDAQ:PRLHView All Competitors DALS Stock Analysis - Frequently Asked Questions When did DA32 Life Science Tech Acquisition IPO? DA32 Life Science Tech Acquisition (DALS) raised $200 million in an initial public offering (IPO) on Wednesday, July 28th 2021. The company issued 20,000,000 shares at a price of $10.00 per share. This page (NASDAQ:DALS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DA32 Life Science Tech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
